Metabolic profile associated with glucose and cholesterol lowering effects of berberine in Sprague-Dawley rats

Metabolomics

Volumn 8, Issue 6, 2012, Pages 1052-1068

  Jiang, Zhangjian ^a   Liu, Feng ^a   Ong, Eng Shi ^b   Li, Sam Fong Yau ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

1H NMR; Berberine; GC MS; Glucose cholesterol lowering; LC MS; Metabolic profile

Indexed keywords

BERBERINE; CHOLESTEROL; FATTY ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; MALTOSE; NUCLEOTIDE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTILIPEMIC ACTIVITY; ARTICLE; BLOOD LEVEL; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; DRUG RESPONSE; FATTY ACID METABOLISM; HISTOPATHOLOGY; LIQUID CHROMATOGRAPHY; LIVER INJURY; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; NONHUMAN; NUCLEOTIDE METABOLISM; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RELIABILITY; TANDEM MASS SPECTROMETRY; URINALYSIS; WEIGHT REDUCTION;

ANIMALIA; RATTUS;

EID: 84868351617     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-012-0407-7     Document Type: Article

References (60)

1. Atherton, H. J., Gulston, M. K., Bailey, N. J., Cheng, K. K., Zhang, W., Clarke, K., et al. (2009). Metabolomics of the interaction between PPAR-α and age in the PPAR-α-null mouse. Molecular System Biology, 5, 259-268.
2. Bateman, J., Chapman, R. D., & Simpson, D. (1998). Possible toxicity of herbal remedies. Scottish Medical Journal, 43(1), 7-15.
3. Bennett, D. (2005). Growing pains for metabolomics. The Scientist, 19, 25-28.
4. Bollard, M. E., Contel, N. R., Ebbels, T. M. D., Smith, L., Beckonert, O., Cantor, G. H., et al. (2010). NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat. Journal of Proteome Research, 9(1), 59-69.
5. Bollard, M. E., Keun, H. C., Beckonert, O., Ebbels, T. M. D., Antti, H., Nicholls, A. W., et al. (2005). Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicology and Applied Pharmacology, 204(2), 135-151.
6. Bronsnan, J. T. (2003). Interorgan amino acid transport and its regulation. Journal of Nutrition, 133(6), 2068S-2072S.
7. Chan, E. (1993). Displacement of bilirubin from albumin by berberine. Biology of the Neonate, 63(4), 201-208.
8. Chan, T. K. Y. (1994). The prevalence use and harmful potential of some Chinese herbal medicines in babies and children. Veterinary and Human Toxicology, 36(3), 238-240.
9. Clayton, T. A., Barker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K. (2009). Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proceedings of the National Academy of Sciences of the United States of America, 106(34), 14728-14733.
10. Coen, M., Lenz, E. M., Nicholson, J. K., Wilson, I. D., Pognan, F., & Lindon, J. C. (2003). An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chemical Research in Toxicology, 16(3), 295-303.
11. Goldstein, J. L., & Brown, M. S. (2001). The cholesterol quartet. Science, 292(5520), 1310-1312.
12. Huang, M., & Graves, L. M. (2003). De novo synthesis of pyrimidine nucleotides; emerging interfaces with signal transduction pathways. Cellular and Molecular Life Science, 60(2), 321-336.
13. Jahnke, G. D., Price, C. J., Marr, M. C., Myers, C. B., & George, J. D. (2006). Developmental toxicity evaluation of berberine in rats and mice. Birth Defects Research, 77(3), 195-206.
14. Jia, X. M., Chen, Y. F., Zidichouski, J., Zhang, J. Z., Sun, C. H., & Wang, Y. W. (2008). Co-administration of berberine and plant stanols synergistically reduces plasma cholesterol in rats. Atherosclerosis, 201(1), 101-107.
15. Jonsson, P., Bruce, S. J., Moritz, T., Trygg, J., Sjöström, M., Plumb, R., et al. (2005). Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. Analyst, 130(5), 701-707.
16. Kong, W. J., Wei, J., Abidi, P., Lin, M. H., Inaba, S., Li, C., et al. (2004). Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine, 10(12), 1344-1351.
17. Kong, W. J., Wei, J., Zuo, Z. Y., Wang, Y. M., Song, D. Q., You, X. F., et al. (2008). Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metabolism Clinical and Experimental, 57(8), 1029-1037.
18. Kuo, C. L., Chi, C. W., & Liu, T. Y. (2004). The anti-flammatory potential of berberine in vitro and in vivo. Cancer Letters, 203(2), 127-137.
19. Lafaye, A., Junot, C., Gall, B. R. L., Fritsch, P., Tabet, J. C., & Ezan, E. (2003). Metabolite profiling in rat urine by liquid chromatography/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity. Rapid Communications in Mass Spectrometry, 17(22), 2541-2549.
20. 1H NMR spectroscopy. Rapid Communications in Mass Spectrometry, 22(16), 2436-2446.
21. 1H nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry with pattern recognition techniques for evaluation of metabolic profile associated with albuminuria. Journal of Proteome Research, 8(4), 1828-1837.
22. 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers, 10(2/3), 173-187.
23. 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. Journal of Pharmaceutical and Biomedical Analysis, 35(3), 599-608.
24. 1H NMR and HPLC-TOF/MS: Time dependant changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. Analyst, 129(6), 535-541.
25. 1H NMR spectroscopy to the metabonomic analysis of rat urine following the intravenous administration of pravastatin. Journal of Pharmaceutical and Biomedical Analysis, 44(4), 845-852.
26. Lin, Y. P., Si, D. Y., Zhang, Z. P., & Liu, C. X. (2009). An integrated metabonomic method for profiling of metabolic changes in carbon tetrachloride induced rat urine. Toxicology, 256(3), 191-200.
27. Lu, C. F., Wang, Y. M., Sheng, Z. G., Liu, G., Fu, Z., Zhao, J., et al. (2010). NMR-based metabonomic analysis of the hepatotoxicity induced by combined exposure to PCBs and TCDD in rats. Toxicology and Applied Pharmacology, 248(3), 178-184.
28. Lv, H., Palacios, G., Hartil, K., & Kurlans, I. J. (2011). Advantages of tandem LC-MS for the rapid assessment of tissue-specific metabolic complexity using a pentafluorophenylpropyl stationary phase. Journal of Proteome Research, 10(4), 2104-2112.
29. Ma, C., Bi, K. S., Zhang, M., Su, D., Fan, X. X., Ji, W., et al. (2010). Toxicology effects of Morning Glory Seed in rat: A metabonomic method for profiling of urine metabolic changes. Journal of Ethnopharmacology, 130(1), 134-142.
30. Mal, M., Koh, P. K., Cheah, P. Y., & Chan, E. C. (2011). Ultra-pressure liquid chromatography/tandem mass spectrometry targeted profiling of arachidonic acid and eicosanoids in human colorectal cancer. Rapid Communications in Mass Spectrometry, 25(6), 755-764.
31. Maxfield, F. R., & Tabas, I. (2005). Role of cholesterol and lipid organization in disease. Nature, 438(1), 612-621.
32. National Commission of Chinese Pharmacopoeia. (2005). Pharmacopoeia of People Republic of China. Beijing: CI. Press.
33. Newsholme, P., Procopio, J., Lima, M. M. R., Pithom-Curi, T. C., & Curi, R. (2003). Glutamine and glutamate-Their central role in cell metabolism and function. Cell Biochemistry and Function, 21(1), 1-9.
34. Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29(11), 1181-1189.
35. Ong, E. S., Chor, C. F., Zou, L., & Ong, C. N. (2009). A multi-analytical approach for metabolomic profiling of zebrafish (Danio rerio) livers. Molecular Biosystems, 5(3), 288-298.
36. Ong, E. S., Zou, L., Li, S., Cheah, P. Y., Eu, K. W., & Ong, C. N. (2010). Molecular & Cellular Proteomics, in press.
37. Plumb, R., Granger, J., Stumpf, C., Wilson, I. D., Evans, J. A., & Lenz, E. M. (2003). Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): Detection of strain, diurnal and gender differences. Analyst, 128(7), 819-823.
38. Plumb, R. S., Stumpf, C. L., Gorenstein, M. V., Castro-Perez, J. M., Dear, G. J., Anthony, M., et al. (2002). Metabonomics: The use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Communications in Mass Spectrometry, 16(20), 1991-1996.
39. Qiu, F., Zhu, Z. Y., Kang, N., Piao, S. J., Qin, G. Y., & Yao, X. S. (2008). Isolation and identification of urinary metabolites of berberine in rats and humans. Drug Metabolism and Disposition, 36(11), 2159-2165.
40. Sach, R. B., & Froehlich, J. L. (1982). Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infection and Immunity, 35(2), 471-475.
41. Sieber, M., Hoffmann, D., Adler, M., Vaidya, V. S., Clement, M., Bonventre, J. V., et al. (2009). Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicological Sciences, 109(2), 336-349.
42. Slupsky, C. M., Cheypesh, A., Chao, D. V., Fu, H., Rankin, K. N., Marrie, T. J., et al. (2009). Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses. Journal of Proteome Research, 8(6), 3029-3036.
43. Slupsky, C. M., Rankin, K. N., Wagner, J., Fu, H., Chang, D., Weljie, A. M., et al. (2007). Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Analytical Chemistry, 79(18), 6995-7004.
44. Sola-Penna, M. (2008). Metabolic regulation by lactate. IUBMB Life, 60(9), 605-608.
45. Stella, C., Beckwith-Hall, B., Cloarec, O., Holmes, E., Lindon, J. C., Powell, J., et al. (2006). Susceptibility of human metabolic phenotypes to dietary modulation. Journal of Proteome Research, 5(10), 2780-2788.
46. Strott, C. A., & Higashi, Y. (2003). Cholesterol sulfate in human physiology: What's it all about? Journal of Lipid Research, 44(7), 1268-1278.
47. Szachowicz-Petelska, B., Sulkowski, S., & Figaszewski, Z. A. (2007). Altered membrane free unsaturated fatty acid composition in human colorectal cancer tissue. Molecular and Cellular Biochemistry, 294(1-2), 237-242.
48. Tan, Y. L., Goh, D., & Ong, E. S. (2006). Investigation of differentially expressed proteins due to the inhibitory effects of berberine in human liver cancer cell line HepG2. Molecular Biosystems, 2(5), 250-258.
49. Tsai, P. L., & Tsai, T. H. (2004). Hepatobiliary excretion of berberine. Drug Metabolism and Disposition, 32(4), 405-412.
50. 1H NMR-based metabolomics in rats. Analytical Chemistry, 81(12), 4734-4741.
51. Waters, N. J., Waterfield, C. J., Farrant, R. D., Holmes, E., & Nicholson, J. K. (2005). Metabonomic deconvolution of embedded toxicity: Application to thioacetamide hepato- and nephrotoxicity. Chemical Research in Toxicology, 18(4), 639-654.
52. Waters, N. J., Waterfield, C. J., Farrant, R. D., Holmes, E., & Nicholson, J. K. (2006). Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: Novel induction of 5-Oxoprolinosis. Journal of Proteome Research, 5(6), 1448-1459.
53. 1H NMR spectroscopy. Toxicology and Applied Pharmacology, 234(3), 314-325.
54. 31P NMR studies with d-serine in rat urine and kidney, time- and dose-related metabolic effects. Chemical Research in Toxicology, 16(10), 1207-1216.
55. Wu, G. Y. (2009). Amino acids: Metabolism, functions, and nutrition. Amino Acids, 37(1), 1-17.
56. Yan, D., Jin, C., Xiao, X. H., & Dong, X. P. (2008). Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. Journal of Biochemical and Biophysical Methods, 70(6), 845-849.
57. Yin, J., Xing, H. L., & Ye, J. P. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism Clinical and Experimental, 57(5), 712-717.
58. Yuan, J., Doucette, C. D., Fowler, W. U., Feng, X. J., Piazza, M., Rabitz, H. A., et al. (2009). Metabolomics-driven quantitative analysis of ammonia assimilation in E. coli. Molecular System Biology, 5, 302-317.
59. Zhou, J. Y., Zhou, S. W., Zhang, K. B., Tang, J. L., Guang, L. X., Ying, Y., et al. (2008). Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats (pharmacology). Biological and Pharmaceutical Bulletin, 31(6), 1169-1176.
60. Zuo, F., Nakamura, N., Akao, T., & Hattori, M. (2006). Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metabolism and Disposition, 34(12), 2064-2072.